| Rocuronium Bromide EP 5.4-Sino-Strong Pharmace
CAS:119302-91-9
Molecular formula:C32H53BrN2O4
Molecular weight: 609.70
Application:Muscular relaxant
(Specification):
All products can meet request of EP 5.4
Appearance Whitish or Yellowish Powder
Solubility Freely soluble in water and anhydrous ethanol
Identification
a) IR Spectrum (KBr)
b) Bromide Test Must comply with EP5.4
Must comply with EP5.4
Test
Appearance Of Solution Must comply with EP5.4
Specific Optical Rotation +28.5- +32.0
pH 8.9- 9.5
Heavy Metals Not more than 10ppm
Water Content Not more than 4.0%
Sulphated ash Not more than 0.1%
Chlorides Not more than 0.1%
Total impurities Not more than 1.5%
Unknown Impurities (each) Not more than 0.1%
Impurity A Not more than 0.2%
Impurity B Not more than 0.3%
Impurity C Not more than 0.3%
Impurity D Not more than 0.1%
Impurity E Not more than 0.1%
Impurity F Not more than 0.1%
Impurity G Not more than 0.1%
Impurity H Not more than 0.1%
Residual Solvents
Acetonitrile Not more than 410 ppm
Dichloromethane Not more than 600 ppm
Assay of Rocuronium Bromide On Anhydrous Basis 99.0% - 101.0%
We supply follow Rocuronium Bromide intermediate:
5a-androst-2-en-17-one
963-75-
17-acetoxy-5a-androsta-2,16-diene 50588-42-6
2a,3a:16a,17a-Diepoxy-17 ? -acetoxy-5a-androstane 50588-22-2
2,3-epoxy-1H-cyclopenta[a]phenanthrene,androstan-17-ol deriv(9CI) 119302-19-1
(2 ,3 )-17-acetoxy-3-hydroxy-2-(4-morpholinyl)-16
-(1-pyrrolidinyl)androstane(9CI)b,17b,16a,5 119302-24-8
(2b,3a,5a,16b,17b)-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol(9CI) 119302-20-4
Mian products:(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline 118864-75-8 Solifenacin Intermediate Rocuronium Bromide 119302-91-9 Muscular relaxant Palonosetron Hydrochloride 135729-62-3 Antihypertension Oxaliplatin 61825-94-3
Zofenopril 81938-43-4 Antihypertension Adiphenine Hydrochloride50-42-0 Antispasmodic Dolasetron Mesylate 115956-13-3 Antihypertension Pregabalin 148553-50-8 Antiepileptic Gransetron Hydrochloride Pancuronium Bromide Vecuronium Bromide
Meptazinol Hydrochloride 59263-76-2 paclitaxel Docetaxel Darifenacin hydrobromide 133099-07-7Solifenacin Succinate Developing
(S)-1,2,3,4-tetrahedro-naphthoic acid 85977-52-2 5,6,7,8-tetrahydro-1-Naphthalenecarboxylicacid 4242-18-6 (R)-1,2,3,4-tetrahedro-naphthoic acid 23357-47-3 (S)-(-)-3-Aminoquinuclidine Dihydrochloride 119904-90-4
N-(1-azabicyalo[2,2,2]oct-3S-yl)-1,2,3,4-tetrahydronaphthalen-1S-ylcarboxamine 17-Oxo-5a-androst-2-ene 963-75-7 17-Acetoxy-5a-and rosta-2,16-diene 50588-42-6 2a,3a:16a,17a-Diepoxy-17b -acetoxy-5a androstane 50588-22-2
2,3-epoxy-1H-cyclopenta[a]phenanthrene,androstan-17-ol deriv 119302-19-1 (2b,3a,5a,16b,17b)-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol 119302-20-4 (2B,3a,5a,16b,17b)-17-acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane 119302-24-8 3-(Benzoylthio)-a-methylpropionic acid 74431-50-8 Dolasetron 115956-12-2 Endo-hexahydro-8-hydroxy-2.6-methano-2H-quinolizin-3(4H)-one 115956-07-5 Dolasetron intermediate |
